Insider Stock Trading History of Dahan Michel


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Dahan Michel since year 2005. The trader's CIK number is 1669737. At the time of this reporting, Dahan Michel is the SVP, Chief Business Officer of Akebia Therapeutics, Inc. . (stock ticker symbol AKBA). See this page for all insider trading activities at Akebia Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Dahan Michel since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-10-02 AKBA Akebia Therapeutics, Inc. Sale 1,398 19.64 27,456
2017-09-28 AKBA Akebia Therapeutics, Inc. Sale 5,000 19.30 96,500
2017-08-15 AKBA Akebia Therapeutics, Inc. Sale 5,000 15.00 75,000
2017-07-03 AKBA Akebia Therapeutics, Inc. Sale 1,399 14.26 19,946
2017-04-03 AKBA Akebia Therapeutics, Inc. Sale 1,401 9.18 12,858
2017-01-01 AKBA Akebia Therapeutics, Inc. Sale 1,629 10.49 17,089
2016-10-01 AKBA Akebia Therapeutics, Inc. Sale 1,401 8.96 12,545
2016-07-05 AKBA Akebia Therapeutics, Inc. Sale 1,402 7.47 10,468
2016-04-04 AKBA Akebia Therapeutics, Inc. Sale 1,401 9.41 13,183

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dahan Michel (SVP, Chief Business Officer of Akebia Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.